0 Commentaires
0 Parts
364 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Biosimilars Create New Growth Opportunities in Rheumatoid Arthritis TherapeuticsThe growing emphasis on early diagnosis and effective long-term management of autoimmune diseases is supporting demand for rheumatoid arthritis drugs. Rheumatoid arthritis is a chronic inflammatory condition that primarily affects the joints and can cause pain, swelling, stiffness, reduced mobility, and joint damage. Treatment typically involves disease-modifying antirheumatic drugs (DMARDs),...0 Commentaires 0 Parts 173 Vue 0 Aperçu
-
Rheumatoid Arthritis Therapeutics Market Sees New Opportunities in Biologic TreatmentsNovember 2, 2026 — The global rheumatoid arthritis therapeutics market is estimated at USD 28.22 billion in 2026 and is projected to reach USD 45.53 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.9% during the forecast period, according to Fact.MR. The market was valued at approximately USD 26.9 billion in 2025. Growing adoption of advanced biologic treatments,...0 Commentaires 0 Parts 7 Vue 0 Aperçu